<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04136457</url>
  </required_header>
  <id_info>
    <org_study_id>MiDy</org_study_id>
    <nct_id>NCT04136457</nct_id>
  </id_info>
  <brief_title>Proteome Remodelling</brief_title>
  <official_title>Proteome Remodelling and Dynamics in Human Skeletal Muscle: Effect of Training</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Morten Hostrup, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the project is to investigate the proteome signature dynamics and remodelling
      in human skeletal muscle induced by exercise training
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 30, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal muscle proteome signature</measure>
    <time_frame>Change from baseline at week 6</time_frame>
    <description>Pathway enrichment analysis of the muscle proteome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle mitochondrial respiration</measure>
    <time_frame>Change from baseline at week 6</time_frame>
    <description>High resolution respirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal oxygen consumption</measure>
    <time_frame>Change from baseline at week 6</time_frame>
    <description>VO2max during incremental exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Change from baseline at week 6</time_frame>
    <description>Lean and fat mass during dual X-ray absorptiometry</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Skeletal muscle mitochondrial supercomplexes</measure>
    <time_frame>Change from baseline at week 6</time_frame>
    <description>Pathway enrichment analysis of mitochondrial supercomplexes</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Skeletal Muscle Physiology</condition>
  <arm_group>
    <arm_group_label>Endurance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endurance training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resistance training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sprint</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sprint training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endurance training</intervention_name>
    <description>Subjects perform a period of endurance training</description>
    <arm_group_label>Endurance</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance training</intervention_name>
    <description>Subjects perform a period of resistance training</description>
    <arm_group_label>Resistance</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sprint training</intervention_name>
    <description>Subjects perform a period of sprint training</description>
    <arm_group_label>Sprint</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women

          -  VO2max &gt; 55 mL/min/kgLM for men and &gt; 50 for women

          -  BMI &lt; 26

        Exclusion Criteria:

          -  Chronic disease deemed by the medical doctor to pose a risk or to affect study
             outcomes

          -  smoking

          -  Use of prescription medicine deemed by the medical to affect study outcomes

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>August Krogh Building</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 21, 2019</study_first_submitted>
  <study_first_submitted_qc>October 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2019</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Morten Hostrup, PhD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

